Better Understand and Prepare for the Significant Challenges Facing the Canadian Reimbursement System! HEOR, PMPRB, HTA, pCPA and COVID-19 – Panel Presentation, Discussion and Q&A Session for Canadian Pharma Companies.

JOIN US

BOOK A 3-HOUR VIRTUAL SESSION

The Canadian pharma industry is in the midst of unprecedented change and uncertainty in the era of #COVID-19.  To help companies better understand and prepare for the significant challenges facing the Canadian reimbursement system, MORSE is pleased to partner with Eversana (Chris Cameron and Sumeet Singh) and IQVIA (Joan McCormick) to offer a 3-hour in-house virtual session.  Please contact info@morseconsulting.ca to learn more about this offering.

COVID-19 Virtual Panel - Challenges Facing Canadian Reimbursement

You're viewing an older edition

The latest CRaFT 2026 report has updated reimbursement data, forecasts, and trends. Get the most current insights.

View the 2026 CRaFT Report → Go to homepage